Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma
Immunology · 2026
DOI: 10.1111/imm.70095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2026. Verfasst von Lihua Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Carcinoma, Hepatocellular, Liver Neoplasms, Glucose. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Beijing Municipal Natural Science Foundation, Excellent Youth Training Programme of Beijing Ditan Hospital, Capital Medical University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Natural killer (NK) cell immunosuppression represents a critical factor in patients with progressive hepatocellular carcinoma (HCC), yet its underlying characteristics at the single‐cell level remain poorly defined. This study investigates the functional and metabolic alterations in NK cells associated with progressive HCC. We performed single‐cell RNA sequencing (scRNA‐seq) on peripheral blood samples from six treatment‐naïve HCC patients, categorised into progressive and stable disease groups based on a 3‐year follow‐up. This was complemented by multicolor flow cytometry of peripheral blood, alongside multicolor fluorescence analyses of paired tumour and adjacent tissues. Our analyses revealed a significant reduction in NK cell proportion and a marked downregulation of immune‐related genes in patients with progressive HCC. scRNA‐seq further identified a distinct NK cell characterised by high expression of HAVCR2 (TIM3). Compared to TIM3 − NK cells, TIM3 + NK cells exhibited an exhausted phenotype, evidenced by upregulated CD39 and TIGIT, impaired functional capacity (reduced CD107a and IFN‐γ) and downregulated key glycolytic enzymes (HK2, ATP5a). Clinically, high TIM3 expression correlated with shorter progression‐free survival and an increased risk of tumour progression. Collectively, our findings delineate a state of NK cell immunosuppression and metabolic impairment in progressive HCC, potentially driven by glycolytic reprogramming and establish TIM3 as a critical marker and potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Lihua Yu, Wanxin Shi, Zhiyun Yang
Förderung
- Beijing Municipal Natural Science Foundation
- Excellent Youth Training Programme of Beijing Ditan Hospital, Capital Medical University
- National Natural Science Foundation of China
- High-Level Public Health Technical Personnel Construction Project
- High-Level Public Health Specialised Talents Project of Beijing Municipal Health Commission
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Yu, L., Jiang, Y., Liu, X., Yan, F., Yan, H., Xie, Y., Shi, W., Shang, Z., Du, J., & Yang, Z. (2026). Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma. Immunology. https://doi.org/10.1111/imm.70095
Vancouver
Yu L, Jiang Y, Liu X, Yan F, Yan H, Xie Y, et al. Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma. Immunology. 2026. doi:10.1111/imm.70095
BibTeX
@article{Yu2026,
author = {Yu, Lihua and Jiang, Yuyong and Liu, Xiaoli and Yan, Fengna and Yan, Huiwen and Xie, Yuqing and Shi, Wanxin and Shang, Zimeng and Du, Juan and Yang, Zhiyun},
title = {Alterations in NK Cell Function and Glucose Metabolism Characteristics in Patients With Progressive Hepatocellular Carcinoma},
journal = {Immunology},
year = {2026},
doi = {10.1111/imm.70095}
}
EUVIMED